Evidence map›Paper›PMID 35022255›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2022

The evolving landscape of sex-based differences in lung cancer: a distinct disease in women.

Meera Ragavan, Manali I Patel

Open access · diamondAbstract read
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 81 citations in OpenAlex.

  1. Sex-specific associations of the bilirubin-to-albumin ratio with lung cancer risk: evidence from Cox regression and causal survival forest analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Sex differences in gene regulation and its impact on cancer incidence.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Emerging Trends in Global Lung Cancer Burden.Seminars in respiratory and critical care medicine · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025
    Article
  19. Observational
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Meera RagavanDivision of Hematology/Oncology, Dept of Medicine, University of California San Francisco, San Francisco, CA, USA meera.ragavan@ucsf.edu.
Manali I PatelDivision of Oncology, Dept of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
University of California, San Francisco · USVA Palo Alto Health Care System · US

Funding

Reducing Disparities in End of Life Cancer CareK23MD013474 · NIMHD · STANFORD UNIVERSITY · PI PATEL, MANALI I · 2018 to 2020
$502k
NIMHD NIH HHS K23 MD013474
6 · The paper itself

Abstract

In stark contrast to a few decades ago when lung cancer was predominantly a disease of men who smoke, incidence rates of lung cancer in women are now comparable to or higher than those in men and are rising alarmingly in many parts of the world. Women face a unique set of risk factors for lung cancer compared to men. These include exogenous exposures including radon, prior radiation, and fumes from indoor cooking materials such as coal, in addition to endogenous exposures such as oestrogen and distinct genetic polymorphisms. Current screening guidelines only address tobacco use and likely underrepresent lung cancer risk in women. Women were also not well represented in some of the landmark prospective studies that led to the development of current screening guidelines. Women diagnosed with lung cancer have a clear mortality benefit compared to men even when other clinical and demographic characteristics are accounted for. However, there may be sex-based differences in outcomes and side effects of systemic therapy, particularly with chemotherapy and immunotherapy. Ongoing research is needed to better investigate these differences to address the rapidly changing demographics of lung cancer worldwide.

Indexed as

Lung NeoplasmsFemaleHumansIncidenceMaleProspective StudiesRisk FactorsSmokeSmoke

Identifiers

PMID35022255
PMCPMC9488944
OpenAlexW4205703243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.